tailieunhanh - Báo cáo y học: "Treatment of Hereditary Angioedema: items that need to be addressed in practice parameter"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học General Psychiatry cung cấp cho các bạn kiến thức về ngành y đề tài: Treatment of Hereditary Angioedema: items that need to be addressed in practice parameter. | Dagen and Craig Allergy Asthma Clinical Immunology 2010 6 11 http content 6 1 11 ALLERGY ASTHMA CLINICAL IMMUNOLOGY REVIEW Open Access Treatment of Hereditary Angioedema items that need to be addressed in practice parameter Callie Dagen1 and Timothy J Craig 2 Abstract Background Hereditary Angioedema HAE is a rare autosomal dominant AD disorder caused by a C1 esterase inhibitor C1-inh deficiency or qualitative defect. Treatment of HAE in many parts of the world fall short and certain items need to be addressed in future guidelines. Objective To identify those individuals who should be on long-term prophylaxis for HAE. Additionally to determine if prodromal symptoms are sensitive and specific enough to start treatment with C-1 INH and possibly other newly approved therapies. Also to discuss who is appropriate to self-administer medications at home and to discuss training of such patients. Methods A literature review PubMed and Google was performed and articles published in peer-reviewed journals which addressed HAE prophylaxis current HAE treatments prodromal symptoms of HAE and self-administration of injected home medications were selected reviewed and summarized. Results Individuals whom have a significant decrease in QOL or have frequent or severe attacks and who fail or are intolerant to androgens should be considered for long-term prophylaxis with C1INH. Prodromal symptoms are sensitive but non-specific and precede acute HAE attacks in the majority of patients. Although the treatment of prodromal symptoms could lead to occasional overtreatment it could be a viable option for those patients able to adequately predict their attacks. Finally self-administration has been shown to be feasible safe and effective for patients who require IV therapy for multiple other diseases to include but not limited to hemophilia. Conclusions Prophylactic therapy treatment at the time of prodromal symptoms and self-administration at home all should allow a .

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.